by PCastro | Mar 29, 2023 | Current
This year, the DRI entered into a new partnership with iTolerance, a Miami-based early-stage regenerative medicine company, with a promising new therapy in development for individuals with type 1 diabetes. The company’s lead platform technology, iTOL-100, is a...
by PCastro | Jan 20, 2023 | Current
One of the world’s leading diabetes experts, Matthias von Herrath, M.D., has been named the new scientific director of the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine. Dr. von Herrath takes over the lead position at the...
Recent Comments